Phio Pharmaceuticals (NASDAQ:PHIO) Receives “Buy” Rating from HC Wainwright
HC Wainwright reissued their buy rating on shares of Phio Pharmaceuticals (NASDAQ:PHIO – Free Report) in a research note published on Wednesday morning,Benzinga reports. HC Wainwright currently has a $4.00 price objective on the stock. Phio Pharmaceuticals Stock Up 2.4 % PHIO opened at $1.74 on Wednesday. The company has a market capitalization of $11.99 […]
HC Wainwright reissued their buy rating on shares of Phio Pharmaceuticals (NASDAQ:PHIO – Free Report) in a research note published on Wednesday morning,Benzinga reports. HC Wainwright currently has a $4.00 price objective on the stock. Phio Pharmaceuticals Stock Up 2.4 % PHIO opened at $1.74 on Wednesday. The company has a market capitalization of $11.99 […]
